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Introduction	  Regulation	  of	  gene	  expression	  determines	  cellular	  identity	  and	  functions.	  Transcription	  factors	  are	  a	  special	  class	  of	  genes	  that	  have	  the	  ability	  to	  modulate	  mRNA	  levels	  in	  a	  cell	  until	   it	   acquires	   the	   predetermined	   phenotype1.	   However,	   the	   full	   sets	   of	   specific	  transcription	   factors	   and	   their	   targets	   are	   yet	   undetermined	   for	   several	   cell	   types.	  Acquiring	   such	   knowledge	   is	   fundamental	   to	   understanding	   cellular	   states,	   and	   is	  applicable	   to	   regenerative	   medicine	   where	   efforts	   are	   made	   to	   engineer	   or	   to	   direct	  differentiation	  towards	  a	  medically	  relevant	  cell	  type2.	  In	  order	   to	   identify	   the	   factors	   and	   their	  direct	   targets,	   several	   approaches	  have	  been	  developed,	   such	   as	   predictive	   (computational)	   methods	   based	   on	   the	   presence	   of	   a	  transcription	   factor	   binding	   site	   (TFBS)	   in	   their	   promoter	   regions3,	   or	   experimental	  methods	  based	  on	  perturbations	  followed	  by	  expression	  level	  measurements4.	  However,	  predictive	  methods	  don’t	   perform	  optimally:	   TFBS	   sequences	   are	   not	  well	   defined	   for	  the	  vast	  majority	  of	  transcription	  factors,	   factors	  from	  the	  same	  family	  often	  bind	  very	  similar	   sequences,	   and	   binding	   events	   may	   be	   predicted	   as	   important	   even	   though	   a	  transcription	  factor	  is	  not	  even	  expressed	  in	  the	  cell.	  Similarly,	  experimental	  approaches	  can’t	  discriminate	  direct	  from	  indirect	  effects	  of	  the	  perturbation.	  Determination	  of	  the	  physical	  binding	  sites	  in	  the	  genome	  is	  also	  possible	  using	  protocols	  such	  as	  chromatin	  immunoprecipitation	   followed	   by	   sequencing	   (ChIP-­‐seq)5,	   but	   these	   methods	   do	   not	  distinguish	  functional	  from	  non-­‐functional	  binding	  either.	  Furthermore,	   regulatory	   interactions	   vary	   between	   cell	   types,	   as	   there	   are	   different	  combinations	  of	  transcription	  factors	  expressed	  and	  different	  chromatin	  configurations	  in	   each	   cell	   type.	   Thus,	   what	   we	   ultimately	   need	   is	   a	   compendium	   of	   regulatory	  networks	   specific	   for	   every	   cell	   type,	   and	  we	   need	  ways	   to	   identify	  which	   factors	   are	  most	   important	   to	   a	   given	   cell	   type.	   The	   FANTOM5	   project	   generated	   nearly	  comprehensive	  sets	  of	  promoters	  with	  corresponding	  expression	  profiles	  across	  a	  large	  collection	   of	   human	   and	   mouse	   samples	   using	   CAGE6,7.	   In	   particular,	   expression	  enrichment	   information	   (an	   indication	   of	   cell	   type	   specificity)	   for	   all	   known	  transcription	  factors	  in	  a	  given	  a	  cell	  type	  are	  provided,	  aiding	  the	  prioritization	  of	  key	  transcription	   factors	   to	   study	   cell-­‐type-­‐specific	   transcriptional	   regulatory	   networks	  (TRNs).	  To	   probe	   regulatory	   interactions,	   we	   devised	   an	   integrated	   approach	   for	   dissecting	  TRNs	   using	   siRNA	   knock	   down	   with	   CAGE	   (KD-­‐CAGE)	   and	   ChIP-­‐seq	   in	   the	   TC-­‐YIK8	  cervical	  cancer	  cell	   line.	  TC-­‐YIK	   is	  stable,	  viable	  and	  expresses	   insulin	  and	  many	  other	  pancreatic	   genes	   and	   transcription	   factors.	   Given	   the	   difficulty	   in	   obtaining	   primary	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human	   beta	   cells	   for	   research,	   our	   results	   may	   be	   of	   interest	   to	   studying	   pancreatic	  transcriptional	  regulation.	  	  
Results	  
The	  TC-­‐YIK	  cell	  line	  expresses	  pancreatic	  genes	  and	  transcription	  factors	  A	   systematic	   review	   of	   TC-­‐YIK	   expressed	   promoters	   confirmed	   the	   presence	   of	  chromogranin-­‐A	  (CHGA),	  gastrin	  (GAST),	  insulin	  (INS),	  ghrelin	  (GHRL)	  and	  transthyretin	  (TTR),	   all	   playing	   key	   roles	   in	   the	   pancreas.	   Compared	   to	   known	   pancreatic	   cell	  catalogues9,	   TC-­‐YIK	   transcriptional	   profile	   shows	   expression	   for	   85%	   of	   the	   beta	   cell	  specific	  genes.	  Mouse	  orthologous	  of	  most	  enriched	  transcription	  factors	  in	  TC-­‐YIK	  were	  expressed	   in	  at	   least	  one	  stage	  of	  pancreatic	  development	  also	  profiled	   in	  FANTOM510	  (Table	  1).	  	  







s	  Transcription	  factors	  with	  enriched	  expression	  in	  TC-­‐YIK	  
NEUROD1	   593	   2.77	   yes	   yes	   Si,	  CA,	  CS	  
INSM1	   519	   2.72	   yes	   yes	   -­‐	  
PAX6	   296	   2.47	   yes	   yes	   Si,	  CA,	  CS	  
NKX6-­‐3	   239	   2.38	   yes	   no	   -­‐	  
ARX	   237	   2.38	   yes	   yes	   Si	  
MLXIPL	   218	   2.34	   yes	   yes	   Si,	  CA	  
RFX6	   146	   2.17	   yes	   yes	   Si,	  CA,	  CS	  
ONECUT2	   151	   2.14	   yes	   yes	   Si,	  CA	  
PAX4	   133	   2.13	   yes	   yes	   Si,	  CA	  
PDX1	   127	   2.11	   yes	   yes	   Si	  
DACH1	   269	   2.05	   yes	   yes	   Si,	  CA	  
ISL1	   102	   2.01	   yes	   yes	   Si,	  CA	  
FEV	   94	   1.98	   yes	   no	   Si	  
HOPX	   168	   1.95	   yes	   yes	   Si,	  CA	  
FOXA2	   88	   1.95	   yes	   yes	   Si	  
ST18	   78	   1.90	   yes	   yes	   -­‐	  
HNF4G	   75	   1.88	   yes	   yes	   -­‐	  
PROX1	   106	   1.84	   yes	   yes	   Si,	  CA	  
HNF4A	   69	   1.84	   yes	   yes	   Si	  
ELF3	   51	   1.71	   yes	   yes	   Si	  
SHOX2	   62	   1.70	   yes	   no	   Si,	  CA	  
NPAS3	   55	   1.63	   no	   yes	   -­‐	  
CDX2	   41	   1.63	   yes	   yes	   -­‐	  
HOXA10	   40	   1.61	   yes	   no	   Si	  
MNX1	   38	   1.59	   yes	   yes	   Si,	  CA	  
ASCL2	   34	   1.54	   no	   yes	   -­‐	  
TFAP2A	   97	   1.53	   yes	   no	   -­‐	  
IRF8	   31	   1.51	   no	   yes	   Si	  
CASZ1	   70	   1.51	   yes	   yes	   -­‐	  
SIX3	   30	   1.49	   no	   no	   Si	  
C11orf9/MYRF	   62	   1.49	   no	   yes	   Si	  
MYT1	   26	   1.43	   yes	   yes	   Si	  
HOXB13	   26	   1.43	   yes	   no	   Si	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ASCL1	   25	   1.42	   yes	   yes	   Si,	  CA	  
NR0B2	   24	   1.41	   yes	   yes	   Si	  
LMX1A	   24	   1.40	   yes	   no	   Si,	  CA,	  CS	  
HSF4	   27	   1.33	   no	   yes	   -­‐	  
HES6	   71	   1.32	   yes	   yes	   -­‐	  
HLF	   23	   1.31	   no	   yes	   Si	  
IRF6	   23	   1.30	   no	   yes	   -­‐	  
DLX6	   19	   1.29	   no	   no	   Si	  
GATA4	   18	   1.28	   yes	   yes	   Si,	  CA	  
Ubiquitous	  transcription	  factors	  expressed	  in	  TC-­‐YIK	  but	  not	  enriched	  
ATF5	   290	   0.73	   no	   yes	   Si,	  CA	  
HMGB2	   243	   0.37	   no	   yes	   Si,	  CA	  
GTF3A	   213	   0.36	   no	   yes	   Si,	  CA	  
HMGA1	   672	   0.34	   yes	   yes	   Si,	  CA	  
TBP	   29	   0.15	   no	   yes	   Si,	  CA	  
TAF9	   80	   0.09	   no	   yes	   Si,	  CA	  
TCF25	   90	   -­‐0.10	   no	   yes	   Si,	  CA	  
TAF10	   75	   -­‐0.33	   no	   yes	   Si,	  CA	  Table	   1.	   List	   of	   enriched	   transcription	   factors.	   Experiments	   abreviations:	   Si=siRNA;	   CA=CAGE;	  CS=Chip-­‐seq.	  	  
3.2.	  Enriched	  transcription	  factors	  are	  required	  to	  maintain	  the	  TC-­‐YIK	  TRN	  	  KD-­‐CAGE11	  identified	  genome-­‐wide	  promoters	  that	  were	  perturbed	  after	  KD	  of	  enriched	  and	   non-­‐enriched	   transcription	   factors.	   Looking	   at	   TC-­‐YIK	   enriched	   promoters	   only	  (expression	  >	  3-­‐fold	   than	  median	  across	  all	  FANTOM5	  samples)	  we	  observed	  a	  down-­‐regulation	  of	  50%	  of	  enriched	  promoters	  in	  the	  KD	  of	  NEUROD1	  and	  up-­‐regulation	  of	  the	  majority	  of	  enriched	  promoters	  in	  ISL1	  KD.	  Using	  a	  measure	  of	  anti/pro	  TC-­‐YIK,	  defined	  as	  the	  fraction	  of	  enriched	  promoters	  in	  the	  down-­‐regulated	  set	  divided	  by	  the	  fraction	  of	   enriched	  promoters	   in	   the	  up-­‐regulated	   set,	  we	   could	  distinguish	   anti	  TC-­‐YIK	   (high	  ratio)	   from	  pro	  TC-­‐YIK	   (low	   ratio)	   transcription	   factors.	  The	  majority	  of	   enriched	  and	  the	   non-­‐enriched	   factors	   appear	   to	   be	   pro-­‐TC-­‐YIK,	   while	   ISL1	   and	   PROX1	   act	   as	  antagonists	  to	  the	  TC-­‐YIK	  state.	  Interestingly,	  MNX1	  is	  pro	  TC-­‐YIK	  but	  appears	  to	  do	  so	  by	  actively	  repressing	  non-­‐enriched	  promoters	  (Figure	  1).	  	  
3.3.	  ChIP-­‐seq	  identifies	  genuine	  binding	  sites	  at	  promoters	  and	  at	  enhancers	  We	  used	  ChIP-­‐seq	  data	  for	  four	  of	  the	  TC-­‐YIK	  enriched	  factors	  (NEUROD1,	  LMX1A,	  RFX6	  and	  PAX6)	  to	  identify	  their	  genomic	  binding	  sites.	  Motif	  enrichment	  analysis	  confirmed	  significant	  enrichment	  for	  the	  relevant	  known	  motifs.	  For	  RFX6	  there	  is	  no	  known	  motif;	  however,	   the	   motifs	   of	   other	   RFX	   family	   members,	   and	   in	   particular	   RFX5,	   were	  overrepresented.	  De-­‐novo	   motif	   finding	   on	   the	   RFX6	   ChIP-­‐seq	   data	   identified	   a	   novel	  motif	   that	   is	   found	   in	   58%	  of	  RFX6	   peaks.	   All	   factors	   often	   bind	   together	   to	   the	   same	  sites,	  and	  seldom	  at	  promoters.	  Subsequent	  comparison	  of	  the	  binding	  sites	  to	  a	  map	  of	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open	  chromatin	  sites	  in	  human	  islet	  cells9	  revealed	  that	  between	  46%	  and	  62%	  of	  peaks	  overlapped	  these	  sites,	  with	  preference	  for	  enhancer	  sites	  (Figure	  2).	  Intriguingly,	   RFX6	   had	   twice	   as	   many	   peaks	   overlapping	   C5	   class	   enhancers	   than	  expected	  (Figure	  2,	  right),	  suggesting	  that	  RFX	  binding	  may	  be	  one	  of	  the	  earliest	  events	  upon	  sites	  opening.	  	  
	  Figure	  1.	  A)	  Up/down	  regulated	  TSSs	  in	  KD-­‐CAGE;	  B)	  Fractions	  of	  up/down-­‐regulated,	  enriched	  and	  non-­‐enriched	  TSS;	  C)	  pro/anti	  TC-­‐YIK	  ratios.	  Adapted	  from	  Figure	  3	  in	  Lizio	  et	  al.	  2015.	  	  
	  Figure	  2.	  Number	  of	  ChIP-­‐seq	  peaks	  overlapping	  across	  4	  factors	  (left)	  and	  percentages	  of	  peaks	  overlapping	  open	  sites	  (right).	  Adapted	  from	  Figure	  4	  in	  Lizio	  et	  al.	  2015.	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Revealing	  TF-­‐promoters	  regulatory	  interaction	  with	  ChIP-­‐seq	  and	  KD-­‐CAGE	  KD-­‐CAGE	   data	   combined	   with	   ChIP-­‐seq	   data	   allowed	   identification	   of	   direct	   and	  functional	  regulation:	  promoters	  affected	  in	  the	  KD	  of	  a	  transcription	  factor	  that	  exhibit	  a	   ChIP	   peak	   of	   the	   same	   factor	   nearby	   were	   considered	   likely	   direct	   targets.	   We	  identified	   317	   and	   1,543	   directly	   regulated	   promoters	   for	   LMX1A	   and	   NEUROD1	  respectively.	  In	  particular,	  NEUROD1	  and	  LMX1A	  were	  found	  targeting	  directly	  several	  other	   enriched	   transcription	   factors	   in	   TC-­‐YIK	   (Figure3).	   Importantly,	   the	   promoters	  within	  1kb	  of	  a	  ChIP-­‐seq	  peak	  were	  down-­‐regulated,	  suggesting	  that	  these	  factors	  work	  as	   activators	   of	   their	   targets.	   In	   the	   case	   of	   RFX6	   and	   PAX6,	   we	   observed	   no	   such	  distance-­‐dependent	  effect,	  suggesting	  that	  either	  these	  factors	  work	  predominantly	  via	  distal	   sites	   or	   that	   the	   small	   number	   of	   ChIP-­‐seq	   peaks	   obtained	   confounded	   the	  analysis.	   Importantly,	  not	  all	  proximal	  sites	  appear	   to	  be	   functional:	   for	  NEUROD1	   and	  
LMX1A	   respectively,	   17%	  and	   18%	  of	   the	   TSSs	  within	   1kb	   of	   a	   ChIP-­‐seq	   peak	   for	   the	  same	   factor	   were	   unaffected	   in	   the	   KD.	   This	   could	   mean	   that	   such	   sites	   are	   non-­‐functional,	  or	  that	  they	  are	  cell-­‐context	  dependent.	  	  	  	  
	  Figure	  3.	  Transcriptional	  regulatory	  network	  of	  TF-­‐TF	  direct	  interactions.	  Yellow=regulators;	  red=targets;	  line	  thickness=strength	  of	  the	  interaction	  	  
Discussion	  We	  presented	  a	  method	  to	  probe	  cell	  type	  specific	  transcriptional	  regulatory	  networks.	  We	   started	   by	   identifying	   cell	   type	   enriched	   transcription	   factors	   and	   then	   use	   a	  combination	   of	   siRNA	   perturbation,	   CAGE	   and	   ChIP-­‐seq	   to	   identify	   their	   direct	   and	  indirect	   targets	   that	   takes	   advantage	   of	   the	   strengths	   of	   all	   techniques:	   ChIP-­‐seq	   can	  identify	   bound	   targets,	   although	   it	   is	   insufficient	   to	   discriminate	   functional	   from	  non-­‐
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functional	   bound	   sites.	   Conversely,	   the	   application	   of	   CAGE	   to	   perturbed	   samples	  identifies	  affected	  genes,	  but	  cannot	  distinguish	  direct	  from	  indirect	  effect.	  In	  particular,	  we	   stressed	   on	   the	   fact	   that	   even	   in	   the	   presence	   of	   a	   protein-­‐DNA	   interaction,	   the	  regulation	  of	  target	  genes	  can	  happen	  only	  if	  the	  site	  of	  interaction	  is	  functional.	  This	  is	  why	  complementary	  techniques	  should	  be	  used	  in	  studying	  TRNs.	  	  Aside	   from	   devising	   a	   general	   strategy	   applicable	   in	   several	   biological	   scenarios	  (development,	   differentiation,	   or	   reprogramming)	   to	   infer	   cell	   type	   specific	   TRNs,	   we	  have	   introduced	   TC-­‐YIK	   as	   a	   model	   to	   study	   transcriptional	   regulation	   of	  neuroendocrine	  genes.	  	  We	  have	  shown	  that	  TC-­‐YIK	  expresses	  key	  transcription	  factors	  known	  to	  be	  involved	  in	  pancreatic	   cell	   development	   and	   differentiation,	   that	   it	   recapitulates	   the	   islet	   cells	  transcriptome,	   and	   that	  NEUROD1,	  LMX1A,	  PAX6	   and	  RFX6	   binding	   sites	   in	  TC-­‐YIK	  are	  enriched	  at	  islet	  cells	  active	  enhancer	  sites.	  Thus,	  such	  a	  cell	  line	  model	  could	  represent	  a	  valid	  vehicle	  to	  improve	  protocols	  aimed	  at	  generating	  pancreatic	  beta	  cells,	  which	  are	  difficult	   to	  obtain	   in	   terms	  of	  quantity,	   isolation	  of	  pure	  populations,	  and	  expansion	   in	  culture.	  We	  have	  shown	  that	  not	  only	  enriched	  but	  also	  non-­‐enriched	  factors	  contribute	  to	  the	  maintenance	   of	   the	  TC-­‐YIK	   state,	   as	   these	   factors	   often	  work	   cooperatively	  with	   state	  specific	   factors.	  The	  majority	  of	  the	  knock-­‐down	  experiements	  revealed	  a	  role	  of	  these	  transcription	  factors	  as	  activators;	  by	  incorporating	  ChIP-­‐seq	  data	  we	  could	  verify	  their	  mode	   of	   action:	   for	   instance,	   we	   confirmed	   that	   both	  NEUROD1	   and	   LMX1A	   work	   as	  direct	  transcriptional	  activators.	  In	  the	  case	  of	  RFX6	  and	  PAX6	  we	  made	  no	  predictions	  of	  their	  direct	  targets	  as	  there	  were	  few	  peaks	  bound	  at	  promoter	  regions	  and	  there	  was	  no	  enrichment	  for	  perturbed	  TSS	  near	  these	  peaks.	  This	  could	  be	  due	  to	  lower	  quality	  or	  less	  efficient	  antibodies	  used	  for	  the	  two	  factors,	  or	  could	  reflect	  lower	  expression	  levels	  compared	  to	  the	  other	  factors.	  	  Lastly,	   the	   study	   on	   TC-­‐YIK	   cell	   line	   taught	   us	   that	   mammalian	   TRN	   models	   should	  incorporate	   distal	   regulatory	   elements	   as	   well	   as	   proximal	   elements.	   That	   could	   be	  achieved	  by	  employing	  chromatin	  conformation	  methods	  to	  be	  combined	  with	  KD-­‐CAGE	  and	   ChIP-­‐seq	   such	   that	   we	   can	   identify	   gold	   standard	   regulatory	   events	   at	   both	  promoters	  and	  enhancers,	  and	  understand	  better	  how	  each	  cell	  type	  is	  wired.	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